
Hanna Kim (Kim) Gaggin MD
Cardiologist, Massachusetts General Hospital Associate Professor, Harvard Medical School Director, Amyloidosis Program
Join to view full profile
55 Fruit StYawkey 5, MGHBoston, MA 02114
Phone+1 617-726-2709
Fax+1 617-643-6844
Dr. Gaggin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hanna (Kim) Gaggin is a Cardiologist based in Boston, MA. She completed her Residency in Internal Medicine at the University of Virginia Medical Center and then went on to do a fellowship in Cardiovascular Disease at UPMC Medical Education.
Education & Training
UPMC Medical EducationFellowship, Cardiovascular Disease, 2007 - 2010
University of Virginia Medical CenterResidency, Internal Medicine, 2003 - 2006
Eastern Virginia Medical SchoolClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2027
PA State Medical License 2007 - 2010
VA State Medical License 2003 - 2006
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017
- CMS Meaningful Use Stage 1 Certification Oncall, Massachusetts General Hospital, 2014, 2017
Clinical Trials
- Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure Start of enrollment: 2016 Apr 07
Publications & Presentations
PubMed
- Machine learning to optimize the diagnostic performance of natriuretic peptides for acute heart failure across age groups.Daniel Perez Vicencio, Dimitrios Doudesis, Alexander J F Thurston, Camille Chenevier-Gobeaux, Yann-Erick Claessens
ESC Heart Failure. 2026-02-03 - Forecasting left ventricular systolic dysfunction in heart failure with artificial intelligence.Teya Bergamaschi, Tiffany Yau, Payal Chandak, Abena Kyereme-Tuah, Judy Hung
Eclinicalmedicine. 2026-02-01 - 2 citationsThe assessment and management of patients with type 2 myocardial infarction: an international Delphi study.Caelan Taggart, Amy V Ferry, Andrew R Chapman, Stacey D Schulberg, Anda Bularga
European Heart Journal. Quality of Care & Clinical Outcomes. 2025-12-19
Journal Articles
- A Clinical and Proteomics Approach to Predict the Presence of Obstructive Peripheral Arterial Disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseas...Shweta R Motiwala, Cian P McCarthy, Nasrien E Ibrahim, Hanna K Gaggin, Joseph M Garasic, Clinical Cardiology
- Predicting New‐Onset HF in Patients Undergoing Coronary or Peripheral Angiography: Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLAN...Nasrien E Ibrahim, Hanna K Gaggin, Shweta R Motiwala, ESC Heart Failure
Press Mentions
Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CMOctober 1st, 2025
eMyosound to Start Cardiac Ultrasound Trial in 3 Boston HospitalsSeptember 8th, 2025
Blood Pressure Drugs Tied to Surprising Fracture RiskMay 22nd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









